Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Stachowicz A
]trideca-2(6)
Formula: C17H14N2O3
LY294002 inactivates Akt/PKB
SQ109 Size:Solid 2 mg Stachowicz ASQ109 is a drug undergoing development for treatment of tuberculosis. SQ109 showed activity against both drug susceptible and Multi drug resistant tuberculosis bacteria, including Extensively drug resistant tuberculosis strains. In preclinical studies SQ109 enhanced the activity of anti tubercular drugs isoniazid and rifampin and reduced by >30% the time required to cure mice of experimental TB. SQ109 is being developed by OOO Infectex in Russia and
US$ 1314.00
US$ 175.50
US$ 23.00
US$ 57.00
US$ 60.00
US$ 121.00
US$ 105.00
US$ 908.00